hycanthone (BioDeep_00000015134)

 

Secondary id: BioDeep_00000179823


代谢物信息卡片


hycanthone

化学式: C20H24N2O2S (356.1558404)
中文名称: 海恩酮
谱图信息: 最多检出来源 Viridiplantae(plant) 60%

分子结构信息

SMILES: CCN(CC)CCN([H])c(c1)c(C(=O)2)c(Sc(c3)c(ccc3)2)c(CO)c1
InChI: InChI=1S/C20H24N2O2S/c1-3-22(4-2)12-11-21-16-10-9-14(13-23)20-18(16)19(24)15-7-5-6-8-17(15)25-20/h5-10,21,23H,3-4,11-13H2,1-2H3

描述信息

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
[Raw Data] CB147_Hycanthone_pos_50eV_CB000056.txt
[Raw Data] CB147_Hycanthone_pos_40eV_CB000056.txt
[Raw Data] CB147_Hycanthone_pos_30eV_CB000056.txt
[Raw Data] CB147_Hycanthone_pos_20eV_CB000056.txt
[Raw Data] CB147_Hycanthone_pos_10eV_CB000056.txt

同义名列表

1 个代谢物同义名

hycanthone



数据库引用编号

15 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Daniel J Warner, Hongming Chen, Louis-David Cantin, J Gerry Kenna, Simone Stahl, Clare L Walker, Tobias Noeske. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals. 2012 Dec; 40(12):2332-41. doi: 10.1124/dmd.112.047068. [PMID: 22961681]
  • M R O'Donovan, M R Freemantle, G Hull, D A Bell, C F Arlett, J Cole. Extended-term cultures of human T-lymphocytes: a practical alternative to primary human lymphocytes for use in genotoxicity testing. Mutagenesis. 1995 May; 10(3):189-201. doi: 10.1093/mutage/10.3.189. [PMID: 7666770]
  • A F Badawi, H A Awney, M H Mostafa. Formation of promutagenic methylation damage in tissue-DNA of mice treated with antischistosomal agents. Cancer letters. 1993 Dec; 75(3):167-73. doi: 10.1016/0304-3835(93)90059-i. [PMID: 8313351]
  • R Martinelli, A C Noblat, E Brito, H Rocha. Schistosoma mansoni-induced mesangiocapillary glomerulonephritis: influence of therapy. Kidney international. 1989 May; 35(5):1227-33. doi: 10.1038/ki.1989.114. [PMID: 2504987]
  • R Martinelli, L J Pereira, H Rocha. The influence of anti-parasitic therapy on the course of the glomerulopathy associated with Schistosomiasis mansoni. Clinical nephrology. 1987 May; 27(5):229-32. doi: NULL. [PMID: 3109794]
  • I C Simoni, M L Mello. Investigation of hycanthone binding to DNA in chromatin with different supra-organization, composition, and function. Acta histochemica. 1986; 79(1):97-105. doi: 10.1016/s0065-1281(86)80106-4. [PMID: 3090842]
  • A A Sabah, C Fletcher, G Webbe, M J Doenhoff. Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice. Experimental parasitology. 1985 Dec; 60(3):348-54. doi: 10.1016/0014-4894(85)90041-4. [PMID: 3935473]
  • J H Ouma, D J Wijers, T K Arap Siongok. The effect of repeated targeted mass treatment on the prevalence of schistosomiasis mansoni and the intensity of infection in Machakos, Kenya. Annals of tropical medicine and parasitology. 1985 Aug; 79(4):431-8. doi: 10.1080/00034983.1985.11811941. [PMID: 3935065]
  • J Clarkson, D A Erasmus. Schistosoma mansoni: an in vivo study of drug-induced autophagy in the gastrodermis. Journal of helminthology. 1984 Mar; 58(1):59-68. doi: 10.1017/s0022149x00028066. [PMID: 6325532]
  • D Cioli, L Pica Mattoccia. Genetic analysis of hycanthone resistance in Schistosoma mansoni. The American journal of tropical medicine and hygiene. 1984 Jan; 33(1):80-8. doi: 10.4269/ajtmh.1984.33.80. [PMID: 6696189]
  • R B Everson, N M Gad-El-Mawla, M A Attia, E M Chevlen, S S Thorgeirsson, L A Alexander, P M Flack, N Staiano, J L Ziegler. Analysis of human urine for mutagens associated with carcinoma of the bilharzial bladder by the Ames Salmonella plate assay. Cancer. 1983 Feb; 51(3):371-7. doi: 10.1002/1097-0142(19830201)51:3<371::aid-cncr2820510302>3.0.co;2-5. [PMID: 6336979]
  • A M Polderman, J P Manshande. Failure of targeted mass treatment to control schistosomiasis. Lancet (London, England). 1981 Jan; 1(8210):27-8. doi: 10.1016/s0140-6736(81)90127-6. [PMID: 6109059]
  • E D Moore, G Powis. Plasma and tissue concentrations of hycanthone in the mouse determined by reversed-phase high-performance liquid chromatography. Journal of chromatography. 1980 Sep; 183(3):372-7. doi: 10.1016/s0378-4347(00)81720-x. [PMID: 7419657]
  • N Araujo, N Katz, E Pinto Dias, C P de Souza. Susceptibility to chemotherapeutic agents of strains of Schistosoma mansoni isolated from treated and untreated patients. The American journal of tropical medicine and hygiene. 1980 Sep; 29(5):890-4. doi: 10.4269/ajtmh.1980.29.890. [PMID: 7435791]
  • N Hahon, T Ong. Action of antischistosomal drugs, hycanthone and its analog 1A-4 N-oxide, on viral interferon induction. Journal of toxicology and environmental health. 1980 Jul; 6(4):705-12. doi: 10.1080/15287398009529889. [PMID: 6158576]
  • M F de Lima e Costa, N Katz, J C Dias. [Reinfection of patients in endemic areas of schistosomiasis mansoni after specific treatment. IV--Observations in Belo Horizonte]. Revista do Instituto de Medicina Tropical de Sao Paulo. 1980 May; 22(3):97-107. doi: NULL. [PMID: 7466152]
  • J M Zeitune, S R Ramos, L C Sugmyama, A A Côrte. [Drug therapy of mansoni schistosomiasis]. Arquivos de gastroenterologia. 1980 Apr; 17(2):88-95. doi: NULL. [PMID: 7213141]
  • A Saéz-Alquézar, N Ohtsuki, H Sette Júnior, A C Magnanelli, S Raia, L C da Silva. Serum enzymatic changes in patients with schistosomiasis treated with oxamniquine or hycanthone. Comparative study. Revista do Instituto de Medicina Tropical de Sao Paulo. 1980 Jan; 22(1 Suppl 4):105-10, 225. doi: NULL. [PMID: 7455503]
  • P Jordan, J A Cook, R K Bartholomew, E Grist, E Auguste. Schistosoma mansoni control in Cul de Sac Valley, Saint Lucia. II. Chemotherapy as a supplement to a focal mollusciciding programme. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1980; 74(4):493-500. doi: 10.1016/0035-9203(80)90066-8. [PMID: 7445046]
  • J S Kovach, C G Moertel, A J Schutt, R T Eagan. Phase I study of hycanthone. Cancer treatment reports. 1979 Nov; 63(11-12):1965-9. doi: NULL. [PMID: 526930]
  • R D Pedro, L C Dias, V Amato Neto, S A De Carvalho. Observations on the treatment of mansoni schistosomiasis with oxamniquine. Revista brasileira de pesquisas medicas e biologicas. 1979 Jun; 12(2-3):207-11. doi: NULL. [PMID: 515473]
  • T H Connor, J Meyne, L Molina, M S Legator. A combined testing protocol approach for mutagenicity testing. Mutation research. 1979 Feb; 64(1):19-26. doi: 10.1016/0165-1161(79)90132-8. [PMID: 375079]
  • T H Connor, G C Forti, P Sitra, M S Legator. Bile as a source of mutagenic metabolites produced in vivo and detected by Salmonella typhimurium. Environmental mutagenesis. 1979; 1(3):269-76. doi: 10.1002/em.2860010309. [PMID: 399910]
  • L Truong, J B Ward, M S Legator. Detection of alkylating agents by the analysis of amino acid residues in hemoglobin and urine. 1. The in vivo and in vitro effects of ethyl methanesulfonate, methyl methanesulfonate, hycanthone methanesulfonate, and naltrexone. Mutation research. 1978 Dec; 54(3):271-81. doi: 10.1016/0165-1161(78)90017-1. [PMID: 740012]
  • N Katz, F Zicker, R S Rocha, V B Oliveira. Re-infection of patients in schistosomiasis mansoni endemic areas after specific treatment. I--influence of age and worm burden. Revista do Instituto de Medicina Tropical de Sao Paulo. 1978 Sep; 20(5):273-8. doi: NULL. [PMID: 725427]
  • S Y Salih, A Voller, A W Woodruff. Serum immunoglobulin concentrations in human S. mansoni and S. haematobium infections in the Sudan, with special reference to the effect of chemotherapy. Tropenmedizin und Parasitologie. 1978 Sep; 29(3):269-74. doi: NULL. [PMID: 726042]
  • S S Legha, W E Grose, G P Bodey. Phase I study of hycanthone. Cancer treatment reports. 1978 Aug; 62(8):1173-6. doi: NULL. [PMID: 356976]
  • C Davison, M Scrime, J Edelson. Species differences in the metabolism of hycanthone. Archives internationales de pharmacodynamie et de therapie. 1977 Nov; 230(1):4-18. doi: NULL. [PMID: 414666]
  • W F Benedict, A Banerjee, A Gardner, P A Jones. Induction of morphological transformation in mouse C3H/10T1/2 clone 8 cells and chromosomal damage in hamster A(T1)C1-3 cells by cancer chemotherapeutic agents. Cancer research. 1977 Jul; 37(7 Pt 1):2202-8. doi: NULL. [PMID: 67887]
  • J C Kallmeyer, E T MacSearraigh, J D Godlonton. Hepatic and renal failure after misuse of hycanthone. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 1977 Jan; 51(4):109-10. doi: NULL. [PMID: 841434]
  • R P Batzinger, E Bueding. Mutagenic activities in vitro and in vivo of five antischistosomal compounds. The Journal of pharmacology and experimental therapeutics. 1977 Jan; 200(1):1-9. doi: . [PMID: 319220]
  • A A Saad, S M El-Zoghby, H F Farag, S M el-Sewedy, L H Girgis, M Moghazy. Biochemical studies on beta-glucuronidase in the urinary bladder of normal and Schistosoma mansoni infected mice treated with hycanthone. Acta vitaminologica et enzymologica. 1977; 31(6):183-6. doi: NULL. [PMID: 581137]
  • A W Senft, D G Senft, G R Hillman, D Polk, S Kryger. Influence of hycanthone on morphology and serotonin uptake of Schistosome mansoni. The American journal of tropical medicine and hygiene. 1976 Nov; 25(6):832-40. doi: 10.4269/ajtmh.1976.25.832. [PMID: 1008128]
  • J A Cook, P Jordan, P Armitage. Hycanthone dose-response in treatment of schistosomiasis mansoni in St. Lucia. The American journal of tropical medicine and hygiene. 1976 Jul; 25(4):602-7. doi: 10.4269/ajtmh.1976.25.602. [PMID: 961979]
  • L C da Silva, S Hoshino-Shimizu, H Kanamura, P G Strassmann, M E Camargo, H Sette, J D Lopes, D A Chamone, S Raia, G R da Silva. Serum antibody changes after repeated chemotherapic series in 'parasitologically cured' patients with schistosomiasis mansoni. Revista do Instituto de Medicina Tropical de Sao Paulo. 1976 May; 18(3):206-10. doi: NULL. [PMID: 951564]
  • K S Warren, A A Mahmoud. Targeted mass treatment: a new approach to the control of schistosomiasis. Transactions of the Association of American Physicians. 1976; 89(?):195-204. doi: NULL. [PMID: 1035444]
  • N Katz. Clinical evaluation of niridazole and hycanthone in schistosomiasis mansoni endemic areas. Journal of toxicology and environmental health. 1975 Nov; 1(2):203-9. doi: 10.1080/15287397509529322. [PMID: 1107578]
  • L C da Silva, S Hoshino-Shimizu, H Kanamura, P G Strassmann, M E Camargo, H Sette, J D Lopes, D A Chamone, S Raia, G R da Silva. Serum antibody changes after chemotherapy of patients with schistosomiasis mansoni. A statistical analysis. Revista do Instituto de Medicina Tropical de Sao Paulo. 1975 Nov; 17(6):344-9. doi: NULL. [PMID: 769138]
  • S M Sieber, R H Adamson. Evaluation of the teratogenic activity of hycanthone in mice and rabbits. Journal of toxicology and environmental health. 1975 Nov; 1(2):309-22. doi: 10.1080/15287397509529331. [PMID: 1206773]
  • E Weber, K Bidwell, M S Legator. An evaluation of the micronuclei test using triethylenemelamine, trimethylphosphate, hycanthone and niridazole. Mutation research. 1975 Apr; 28(1):101-6. doi: 10.1016/0027-5107(75)90319-x. [PMID: 1095914]
  • A Z El-Abdin, G Samy, A H Mousa, E H El-Raziky, M Z Roshdy, H Abd-El-Rahman, S Hafez, I A Adham. The effect of a second dose of hycanthone alone and with progesterone caproate on the cure rate and the side reactions of hycanthone in the treatment of S. haematobium infected cases. Egyptian journal of bilharziasis. 1974; 1(1):117-33. doi: NULL. [PMID: 4619883]
  • A H Mousa, A Z El-Abdin, A A El-Garem, E H El-Raziky, A A Fadl. Therapeutic evaluation of hycanthone in school children in rural endemic area in Egypt. Egyptian journal of bilharziasis. 1974; 1(1):65-83. doi: NULL. [PMID: 4469236]